Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis.
暂无分享,去创建一个
[1] B. Göke,et al. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models. , 1989, Gastroenterology.
[2] L. Ferrell,et al. Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor. , 1988, Gastroenterology.
[3] P. Lankisch,et al. When should treatment of acute experimental pancreatitis be started? , 1988, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.
[4] W. Steinberg,et al. Treatment of acute pancreatitis: Comparison of animal and human studies , 1987 .
[5] P. Lankisch,et al. Influence of buprenorphine on acute experimental pancreatitis , 1987, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.
[6] I. Ihse,et al. Influence of Peritoneal Lavage on Objective Prognostic Signs in Acute Pancreatitis , 1986, Annals of surgery.
[7] S. C. Kraft. Acute Pancreatitis: Advances in Pathogenesis, Diagnosis and Treatment , 1985 .
[8] R. Williamson,et al. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. , 1985, The New England journal of medicine.
[9] F. Rosato,et al. Peritoneal lavage treatment of experimental pancreatitis. , 1972, The Journal of surgical research.
[10] B. Rasmussen. Hypothermic peritoneal dialysis in the treatment of acute experimental hemorrhagic pancreatitis. , 1967, American journal of surgery.
[11] L. Carey,et al. Peritoneal lavage in experimental pancreatitis in dogs. , 1966, American journal of surgery.